K-CELLS AND GLUCOSE-DEPENDENT INSULINOTROPIC POLYPEPTIDE IN HEALTH AND DISEASEYOUNG MIN CHO; KIEFFER, Timothy J.Vitamins and hormones. 2010, Vol 84, pp 111-150, issn 0083-6729, 40 p.Article

CENTRAL REGULATION OF GLUCOSE-DEPENDENT INSULINOTROPIC POLYPEPTIDE SECRETIONYAVROPOULOU, Maria P; YOVOS, John G.Vitamins and hormones. 2010, Vol 84, pp 185-201, issn 0083-6729, 17 p.Article

Pleiotropic Effects of GIP on Islet Function Involve OsteopontinLYSSENKO, Valeriya; ELIASSON, Lena; TANEERA, Jalal et al.Diabetes (New York, NY). 2011, Vol 60, Num 9, pp 2424-2433, issn 0012-1797, 10 p.Article

GLUCOSE-DEPENDENT INSULINOTROPIC POLYPEPTIDE (GASTRIC INHIBITORY POLYPEPTIDE; GIP)MCLNTOSH, Christopher H. S; WIDENMAIER, Scott; KIM, Su-Jin et al.Vitamins and hormones. 2009, Vol 80, pp 409-471, issn 0083-6729, 63 p.Article

What do we know about the secretion and degradation of incretin hormones?DEACON, Carolyn F.Regulatory peptides. 2005, Vol 128, Num 2, pp 117-124, issn 0167-0115, 8 p.Conference Paper

Glucose metabolism is altered after loss of L cells and α-cells but not influenced by loss of K cellsPEDERSEN, J; UGLEHOLDT, R. K; JØRGENSEN, S. M et al.American journal of physiology. Endocrinology and metabolism. 2013, Vol 67, Num 1, issn 0193-1849, E60-E73Article

Reduced insulinotropic effect of gastric inhibitory polypeptide in first-degree relatives of patients with type 2 diabetesMEIER, Juris J; HÜCKING, Katrin; HOLST, Jens J et al.Diabetes (New York, NY). 2001, Vol 50, Num 11, pp 2497-2504, issn 0012-1797Article

The incretin hormones: from scientific discovery to practical therapeuticsMUDALIAR, S; HENRY, R. R.Diabetologia (Berlin). 2012, Vol 55, Num 7, pp 1865-1868, issn 0012-186X, 4 p.Article

Rolling circle amplification of genomic templates for inverse PCR (RCA―GIP): a method for 5'- and 3'-genome walking without anchoringTSAFTARIS, Athanasios; PASENTZIS, Konstantinos; ARGIRIOU, Anagnostis et al.Biotechnology letters. 2010, Vol 32, Num 1, pp 157-161, issn 0141-5492, 5 p.Article

Gastro-intestinal hormones GIP and GLP-1KIEFFER, T. J.Annales d'endocrinologie. 2004, Vol 65, Num 1, pp 13-21, issn 0003-4266, 9 p.Conference Paper

The Effect of Exogenous Glucose-Dependent Insulinotropic Polypeptide in Combination With Glucagon-Like Peptide-1 on Glycemia in the Critically IIILEE, Michael Y; FRASER, Jonathan D; HOROWITZ, Michael et al.Diabetes care. 2013, Vol 36, Num 10, pp 3333-3336, issn 0149-5992, 4 p.Article

Comparison of sub-chronic metabolic effects of stable forms of naturally occurring GIP(1-30) and GIP(1-42) in high-fat fed miceGAULT, Victor A; PORTER, David W; IRWIN, Nigel et al.Journal of endocrinology. 2011, Vol 208, Num 3, pp 265-271, issn 0022-0795, 7 p.Article

Evolutionary expression of glucose-dependent-insulinotropic polypeptide (GIP)MUSSON, Michelle C; JEPEAL, Lisa I; FINNERTY, John R et al.Regulatory peptides. 2011, Vol 171, Num 1-3, pp 26-34, issn 0167-0115, 9 p.Article

GIP Does Not Potentiate the Antidiabetic Effects of GLP-1 in Hyperglycemic Patients With Type 2 DiabetesMENTIS, Nikolaos; VARDARLI, Irfan; KÖTHE, Lars D et al.Diabetes (New York, NY). 2011, Vol 60, Num 4, pp 1270-1276, issn 0012-1797, 7 p.Article

Palmitic acid in the sn-2 position decreases glucose-dependent insulinotropic polypeptide secretion in healthy adultsFILIPPOU, A; BERRY, S. E; BAUMGARTNER, S et al.European journal of clinical nutrition. 2014, Vol 68, Num 5, pp 549-554, issn 0954-3007, 6 p.Article

Evolutionary conservation of glucose-dependent insulinotropic polypeptide (GIP) gene regulation and the enteroinsular axisMUSSON, Michelle C; JEPEAL, Lisa I; SHARIFNIA, Torfay et al.Regulatory peptides. 2010, Vol 164, Num 2-3, pp 97-104, issn 0167-0115, 8 p.Article

Structurally modified analogues of glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) as future antidiabetic agentsGREEN, Brian D; GAULT, Victor A; O'HARTE, Finbarr P. M et al.Current pharmaceutical design. 2004, Vol 10, Num 29, pp 3651-3662, issn 1381-6128, 12 p.Article

Downregulation of GLP-1 and GIP receptor expression by hyperglycemia: Possible contribution to impaired incretin effects in diabetesGANG XU; KANETO, Hideaki; LAYBUTT, D. Ross et al.Diabetes (New York, NY). 2007, Vol 56, Num 6, pp 1551-1558, issn 0012-1797, 8 p.Article

Gastric Inhibitory Polypeptide: the neglected incretin revisitedMEIER, Juris J; NAUCK, Michael A; SCHMIDT, Wolfgang E et al.Regulatory peptides. 2002, Vol 107, Num 1-3, pp 1-13, issn 0167-0115Article

Evidence that the major degradation product of glucose-dependent insulinotropic polypeptide, GIP(3-42), is a GIP receptor antagonist in vivoGAULT, V. A; PARKER, J. C; HARRIOTT, P et al.Journal of endocrinology. 2002, Vol 175, Num 2, pp 525-533, issn 0022-0795, 9 p.Article

GIP and GLP-1 as incretin hormones : Lessons from single and double incretin receptor knockout miceHANSOTIA, Tanya; DRUCKER, Daniel J.Regulatory peptides. 2005, Vol 128, Num 2, pp 125-134, issn 0167-0115, 10 p.Conference Paper

Glucose-dependent insulinotropic polypeptide (GIP): anti-diabetic and anti-obesity potential?GAULT, Victor A; O'HARTE, Finbarr P. M; FLATT, Peter R et al.Neuropeptides (Edinburgh). 2003, Vol 37, Num 5, pp 253-263, issn 0143-4179, 11 p.Article

Glucose-dependent insulinotropic polypeptide induces cytokine expression, lipolysis, and insulin resistance in human adipocytesTIMPER, Katharina; GRISOUARD, Jean; CHRIST-CRAIN, Mirjam et al.American journal of physiology. Endocrinology and metabolism. 2013, Vol 67, Num 1, issn 0193-1849, E1-E13Article

Preserved GLP-1 and exaggerated GIP secretion in type 2 diabetes and relationships with triglycerides and ALTALSSEMA, Marjan; RIJKELIJKHUIZEN, Josina M; DEKKER, Jacqueline M et al.European journal of endocrinology. 2013, Vol 169, Num 4, pp 421-430, issn 0804-4643, 10 p.Article

Glucose-Dependent Insulinotropic Polypeptide Receptors in Most Gastroenteropancreatic and Bronchial Neuroendocrine TumorsWASER, Beatrice; REHMANN, Ruth; SANCHEZ, Claire et al.The Journal of clinical endocrinology and metabolism. 2012, Vol 97, Num 2, pp 482-488, issn 0021-972X, 7 p.Article